Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 9,088 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

GE HealthCare Technologies logo with Medical background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,908,710 shares of the company's stock after selling 9,088 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.64% of GE HealthCare Technologies worth $272,982,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. LGT Financial Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies during the third quarter worth $26,000. Pathway Financial Advisers LLC purchased a new position in GE HealthCare Technologies during the first quarter worth $25,000. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies during the third quarter worth $26,000. Finally, Darwin Wealth Management LLC purchased a new position in GE HealthCare Technologies during the third quarter worth $31,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and dropped their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective for the company. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. Finally, Stifel Nicolaus lifted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a research note on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $94.36.

Read Our Latest Report on GEHC

GE HealthCare Technologies Stock Up 0.3 %

Shares of GEHC stock traded up $0.22 on Friday, hitting $83.22. The stock had a trading volume of 1,277,723 shares, compared to its average volume of 3,071,344. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The business has a 50 day moving average price of $87.78 and a 200 day moving average price of $83.62. The company has a market cap of $38.02 billion, a PE ratio of 22.86, a P/E/G ratio of 2.97 and a beta of 1.24. GE HealthCare Technologies Inc. has a one year low of $66.39 and a one year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm's quarterly revenue was up .9% on a year-over-year basis. During the same period in the previous year, the company posted $0.99 earnings per share. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's payout ratio is presently 3.85%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Articles

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Should you invest $1,000 in GE HealthCare Technologies right now?

Before you consider GE HealthCare Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.

While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines